Hiroaki Kitaoka - Publications

Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 17, 2026

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: July 01, 2026

Sex Differences in Characteristics and Outcomes Among Patients With Hypertrophic Cardiomyopathy: Insights From the REVEAL-HCM Study.

Journal: Journal of the American Heart Association

Published: June 23, 2026

Impact of Cardiorenal Anemia Syndrome on Physical Function and Clinical Outcomes in Older Patients with Acute Heart Failure.

Journal: Archives of gerontology and geriatrics

Published: April 29, 2026

Cardiac resynchronization therapy in patients with dilated phase of hypertrophic cardiomyopathy in a Japanese regional cohort.

Journal: Journal of cardiology

Published: April 15, 2026

JCS 2026 Guideline on the Management of Infective Endocarditis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

The Burden of Transthyretin Amyloid Cardiomyopathy on Caregivers and Patients in Japan: A Cross‑Sectional Real‑World Survey.

Journal: Advances in therapy

Published: March 17, 2026

Longitudinal Changes in Hematological Status and Functional Capacity During Hospitalization Are Associated With Clinical Outcomes in Older Patients With Acute Decompensated Heart Failure.

Journal: Circulation reports

Published: March 09, 2026

Development and Validation of a Risk Score Predicting Medication Non-adherence in Patients with Heart Failure.

Journal: Biological & pharmaceutical bulletin

Published: February 18, 2026

Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: February 12, 2026

Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM Study.

Journal: Circulation. Heart failure

Published: February 04, 2026